Abstract Details
|
Damiano M. Rovituso
(University of Wuerzburg)
PRESENTER |
No disclosure on file |
| Claudia Kaiser, MD (MSD Merck, Sharp and Dohme) | No disclosure on file |
| Michael Schroeter (Dept. of Neurology, University Hospital Cologne) | No disclosure on file |
| Christoph Kleinschnitz, MD (University Hospitals Essen, Dep. of Neurology) | Dr. Kleinschnitz has nothing to disclose. |
| No disclosure on file | |
| Michael L. Reed, PhD (Vedanta Research) | The institution of Dr. Reed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Reed has received research support from Allergan. The institution of Dr. Reed has received research support from Dr Reddy's Labs/Promius. The institution of Dr. Reed has received research support from Allay Lamp. Dr. Reed has a non-compensated relationship as a Research Analyst with National Headache Foundation that is relevant to AAN interests or activities. |